Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Change in Inventory (2023 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Change in Inventory for 3 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 135.9% to -$2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Dec 2025, up 91.81% year-over-year, with the annual reading at $11.8 million for FY2025, 91.81% up from the prior year.
  • Change in Inventory for Q4 2025 was -$2.0 million at Phathom Pharmaceuticals, down from -$395000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $12.3 million in Q1 2025, with the low at -$2.0 million in Q4 2025.
  • Average Change in Inventory over 3 years is $2.7 million, with a median of $417000.0 recorded in 2024.
  • Peak annual rise in Change in Inventory hit 2863.46% in 2025, while the deepest fall reached 194.5% in 2025.
  • Over 3 years, Change in Inventory stood at $9.3 million in 2023, then plummeted by 40.24% to $5.6 million in 2024, then tumbled by 135.9% to -$2.0 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at -$2.0 million, -$395000.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.